WEE1 and Alzheimer disease: So there are certain perspectives that protein kinase inhibitors for AD therapy may show promising effects in the pathophysiological AD process on one hand and for a more effective therapy on the other hand with respect to the knowledge that present drugs are no real perspective drugs to effectively influence the disease progression.